Human clinical trial success of new drug candidate to treat viral arthritis caused by mosquito-borne infections.
Some successful rheumatoid arthritis therapies may help us better understand how to treat people with mosquito-borne viral diseases.
A new Griffith University study aims to develop drugs to treat alphavirus infection such as Ross River, Chikungunya, O’nyong’nyong and...
Groundbreaking research linking an immune protein to the debilitating condition of virus-induced arthritis and viral exacerbation of rheumatoid arthritis, is...
Lara Herrero received the Prize for New Innovators in the 2023 Prime Minister’s Prizes for Science at a ceremony in Canberra last night.
Living through a global pandemic over the past year has seen all of us expanding our vocabularies. We now understand terms like PPE, social distancing and contact tracing. But just when perhaps we thought we had a handle on most of the terminology, we’re faced with another set of new words: mutation, variant and strain.
Dr Lara Herrero, research leader at Griffith University’s Institute for Glycomics, has been honoured with the Creating Change Award at...
Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.
Institute for Glycomics scientist Dr Lara Herrero has been recognised for scientific excellence with a 2014 Queensland Young Tall Poppy Science Award.
A trio of emerging Griffith University health scientists have been named as Queensland Young Tall Poppies for 2021.
